Clinical Trial Update: Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fixed combination of vildagliptin and metformin versus individual components in drug-naive type 2 diabetes patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)
• Vildagliptin/metformin fixed combination (vildagliptin/metformin)
• metformin (metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED